Fangzhu Zhao1,2,3, Meng Yuan4, Celina Keating1,2,3, Namir Shaabani2, Oliver Limbo3,5, Collin Joyce1,2,3, Jordan L. Woehl3,5, Shawn Barman1,2,3, Alison Burns1,2,3, Quoc Tran3,5, Xueyong Zhu4, Michael J. Ricciardi6, Linghang Peng2, Jessica Smith3,5, Deli Huang2, Bryan Briney7,1,2, Devin Sok1,2,3,5, David Nemazee2, John R. Teijaro2, Ian A. Wilson1,4,3,8, Dennis R. Burton1,2,3,9, Joseph G. Jardine3,5
1Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.
2Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.
3IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.
4Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA
5IAVI, New York, NY 10004, USA
6Department of Pathology, George Washington University, Washington, DC 20052, USA.
7Center for Viral Systems Biology, Scripps Research Institute, La Jolla, CA 92037, USA.
8Skaggs Institute for Chemical Biology, Scripps Research Institute, La Jolla, CA 92037, USA.
9Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA 02139, USA
